MASSARI, ADA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 440
EU - Europa 101
AS - Asia 74
SA - Sud America 19
AF - Africa 1
OC - Oceania 1
Totale 636
Nazione #
US - Stati Uniti d'America 437
CN - Cina 42
IT - Italia 39
RU - Federazione Russa 22
SE - Svezia 22
BR - Brasile 18
SG - Singapore 16
VN - Vietnam 5
DE - Germania 4
FI - Finlandia 4
ID - Indonesia 4
CA - Canada 3
AT - Austria 2
ES - Italia 2
FR - Francia 2
GB - Regno Unito 2
IN - India 2
JP - Giappone 2
AL - Albania 1
AU - Australia 1
CI - Costa d'Avorio 1
EC - Ecuador 1
HK - Hong Kong 1
NL - Olanda 1
OM - Oman 1
UZ - Uzbekistan 1
Totale 636
Città #
Fairfield 79
Woodbridge 64
Chandler 49
Ashburn 33
Cambridge 26
Houston 23
Seattle 23
Nyköping 21
Wilmington 21
Bari 18
Ann Arbor 11
Beijing 11
Singapore 9
New York 6
Dong Ket 5
Inglewood 5
Nanchang 5
Roxbury 5
Dearborn 4
Jakarta 4
Lawrence 4
Nanjing 4
Redwood City 4
Shenyang 4
Brooklyn 3
Des Moines 3
Los Angeles 3
Milan 3
Sennori 3
Council Bluffs 2
Guangzhou 2
Jacksonville 2
Mcallen 2
Moscow 2
Murcia 2
Princeton 2
San Mateo 2
Santa Clara 2
Sassari 2
Toronto 2
Betim 1
Campinas 1
Changsha 1
Chongqing 1
Grand-Bassam 1
Haikou 1
Hefei 1
Indiana 1
Itambé 1
Itapema 1
Jinan 1
Jinhua 1
Joinville 1
Kunming 1
La Troncal 1
Lagoão 1
Leawood 1
Liverpool 1
London 1
Montignoso 1
Muriaé 1
Muscat 1
Norma 1
Nuremberg 1
Nürnberg 1
Ottawa 1
Piraquara 1
Porto Alegre 1
Pune 1
Ribeirão das Neves 1
Rio de Janeiro 1
San Diego 1
Santo Antônio do Descoberto 1
Shaoxing 1
Sombrio 1
Sydney 1
São João Batista 1
São Lourenço da Mata 1
São Vicente 1
Tashkent 1
Tianjin 1
Timbaúba 1
Torino 1
Três Corações 1
Tsuen Wan 1
Valenzano 1
Vienna 1
Wuhan 1
Zhengzhou 1
Totale 524
Nome #
Assessment of resveratrol, apocynin and taurine on mechanical-metabolic uncoupling and oxidative stress in a mouse model of Duchenne muscular dystrophy: a comparison with the gold standard, α-methyl prednisolone. 147
Contractile efficiency of dystrophic mdx mouse muscle: In vivo and ex vivo assessment of adaptation to exercise of functional end points 144
Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy. 126
Increased sodium channel use-dependent inhibition by a new potent analogue of tocainide greatly enhances in vivo antimyotonic activity 114
null 93
Induction of mitochondrial dysfunction in patients under cardiopulmonary by-pass: preliminary results 72
Totale 696
Categoria #
all - tutte 2.495
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.495


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202025 0 0 0 0 0 0 0 0 0 10 11 4
2020/2021148 13 4 8 21 6 8 18 2 11 30 20 7
2021/202251 1 5 0 1 1 5 4 1 5 7 10 11
2022/202397 9 15 6 9 13 16 0 10 13 0 6 0
2023/202427 1 4 2 4 2 8 0 0 1 3 0 2
2024/202599 11 2 8 7 5 11 22 22 9 2 0 0
Totale 696